Express Pharma

Acute myeloid leukaemia market to reach $5.1 billion by 2029: GlobalData

This growth will be driven by label expansions of the already successful drugs Venclexta, Tibsovo, Idhifa and Xospata, as well as by a strong late-stage pipeline.

0 518